Recent Updates
Recently added Catalysts
PRGO Negative Sentiment Score: 20/100

PERRIGO COMPANY PLC (NYSE: PRGO) DEADLINE ALERT Bernstein Liebhard LLP Reminds Perrigo Company plc Investors of Upcoming Deadline

Key Takeaway: Bernstein Liebhard LLP has alerted investors of Perrigo Company plc about a pending deadline related to a securities fraud class action lawsuit. This lawsuit alleges that the company made false statements regarding its infant formula business acquired from Nestlé. Investors who purchased Perrigo shares between February 27, 2023, and November 4, 2025, may need to consider their legal options. The deadline to file as a lead plaintiff is January 16, 2026.

Market Sentiment Analysis

CONCERNS & RISKS

  • A securities fraud class action lawsuit has been filed against Perrigo.
  • Allegations include misrepresentations concerning the infant formula business.
  • Investors who purchased shares during specified dates are potentially affected.
  • A deadline for filing as lead plaintiff is fast approaching.

Full Press Release Details

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
Do you, or did you, own shares of Perrigo Company plc (NYSE: PRGO)?
Did you purchase your shares between February 27, 2023 and November 4, 2025, inclusive?
Did you lose money in your investment in Perrigo Company plc?
Do you want to discuss your rights?
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
If you purchased or acquired Perrigo securities, and/or would like to discuss your legal rights and options please visit Perrigo Company plc Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
A lawsuit was filed in the United States District Court for the Southern District of New York on behalf of investors (the “Class”) who purchased or acquired the securities of Perrigo between February 27, 2023 and November 4, 2025, inclusive, alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its senior officers.
According to the lawsuit, Defendants made misrepresentations concerning the Company’s infant formula business it acquired from Nestlé.
If you wish to serve as lead plaintiff for the Class, you must file papers by January 16, 2026. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.
ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Investor Relations Manager
Bernstein Liebhard LLP

Tags

perrigo class action

Frequently Asked Questions

What is the deadline for filing as lead plaintiff?

The deadline to file as lead plaintiff is January 16, 2026.

What dates are covered by the Perrigo lawsuit?

The lawsuit covers purchases made between February 27, 2023, and November 4, 2025.

What are the allegations in the Perrigo lawsuit?

The lawsuit alleges that Perrigo misrepresented its infant formula business.

Do shareholders pay fees for representation?

Shareholders incur no fees or expenses; representation is on a contingency fee basis.

Who should be contacted for more information?

For more information, contact Investor Relations Manager Peter Allocco at (212) 951-2030.

Last updated: Dec 15, 2025